University of Colorado Cancer Center Blog Archive
Head over to the new CU Cancer Center blog to see the latest research, patient stories, and more from the center.
CU Cancer Center shared resources help research, diagnose, treat COVID-19
Advanced technologies for cancer research aid the fight against COVID-19
Mental Health Tips for Patients with Cancer During COVID-19
CU Cancer Center clinical psychologist offers mental health tips for patients with cancer during COVID-19.
CU Mass Spectrometry Shared Resource works to predict embolism in COVID-19
Blocking metabolic pathways could help doctors stop COVID-19 associated blood clots
Does getting a suntan really protect against burns that cause skin cancer?
“I know directly from my research that a tan is damage,” says Neil Box, PhD.
D. Ross Camidge, MD, PhD: COVID-19 lung cancer treatment diary
“Medical situations are the explosions we run toward rather than away from.”
It’s National Cancer Research Month. Here’s what CU Cancer Center did this year!
From basic science to clinical trials, CU Cancer Center moving the needle on cancer discovery and care
Sun protection strategies for COVID19 outdoor recreation
“For some people, a sunburn could be as dangerous as a virus exposure,” says Neil Box, PhD.
Christopher Lieu, MD, named Associate Director of Clinical Research at the CU Cancer Center
The CU Cancer Center is excited to announce that Chris Lieu, MD, is the Associate Director of Clinical Research
Variation in how side effects are reported leaves first impressions of new anti-cancer drugs open to manipulation
Differences in side effect reporting makes some drugs seem safer or less safe than they really are
Study shows fewer kids enrolling in cancer clinical trials
From 40-70 percent in the 1990s, to 20-25 percent in the early 2000s, to 19.9 percent today.
CCSP Launches COVID-19 toolkit for patient navigators
The Colorado Cancer Screening Program (CCSP) for Patient Navigation is working with the safety net clinics throughout Colorado to help respond to the coronavirus and COVID-19.
With smaller clinical trials, it may be up to doctors to notice rare drug side effects
Right-colon twist with high-dose osimertinib highlights need for doctor vigilance with new cancer drugs
Pancreatic Cancer Journey Underscores Importance of a Second Opinion
After being told her tumor was inoperable, Nancy White turns to CU Cancer Center and undergoes lifesaving surgery
New mental health challenges for cancer patients during COVID-19
“By the time a patient diagnosed today finishes their treatment, maybe we’ll all be ready to get back to our lives.”
Colorado study overturns ‘snapshot’ model of cell cycle in use since 1974
CU study shows cells don’t depend on a snapshot to decide whether to replicate – it’s more like a movie.
Experimental medication to prevent heart disease may treat chemo-resistant ovarian cancer
Benjamin Bitler, PhD Most ovarian cancer starts in fallopian tubes. Then it sloughs from its site of origin and floats around in fluid until finding new sites of attachment. It’s not easy for cancer cells to survive away from their moorings. Observations by ovarian...
Study: Despite failures, chemo still promising against dangerous childhood brain cancer, DIPG
“The results were surprising and encouraging,” says Adam Green, MD.
In new role at CU, Jamie Studts works to reduce stigma blocking use of lung cancer screening
His challenge: to help navigate a paradigm shift in the way we prevent, diagnose, and treat the disease.
Leading chloroquine scientists weigh in on drug as possible COVID-19 treatment
“Two independent sources with the same scientific finding make you think it’s true.”
COVID-19 recommendations for patients receiving anti-cancer immunotherapy
Could medicines that activate the immune system *protect* against COVID-19 infection?
What Patients Should Know About Anti-Cancer Immunotherapy Side Effects
“I tell patients they should call their provider with any new symptom, says Ryan Weight, DO, MS.
Post-diagnosis disparities drive poorer outcomes for pediatric Black and Hispanic brain cancer patients
52 percent of White patients lived five years from diagnosis; only 44 percent of African American patients and 45 percent of Hispanic patients reached a similar milestone.
African Americans, Hispanics less likely to receive recommended lung cancer imaging
African American patients about half as likely as non-Hispanic whites to receive PET-CT imaging
Humans of Anschutz: Heather Leach, PhD
Heather Leach, PhD, wants to get cancer survivors moving and keep them moving!
COVID-19 Recommendations for Cancer Patients
“Cancer patients should take the same precautions as others in high-risk populations,” says Thomas Campbell, MD
University of Colorado Cancer Center adds years back to bile duct cancer patient’s life
Lydia Mallernee was diagnosed in March 2018 with advanced cancer of the bile duct. After receiving an IV immunotherapy, she has no evidence of disease since August 2019.
“Did We Do the Right Thing?”
Nicole and David Garrett face the question of fertility preservation in their 4-year-old
Community climbing competition raises funds for CU Cancer Center research
Feb 29, 2020 event for all ages/abilities!
Colorado study points immune system at triple-negative breast cancer
HO-1 may help TNBC hide from the immune system — and a drug already exists to stop it.
What is Cancer?
All we really needed to know about cancer comes from an 8-year-old on the Pearl Street Mall.